ArticleSurgical endoscopy2026
Clinical feasibility analysis of reducing the incidence of pancreatic fistula after laparoscopic distal pancreatectomy by using a pancreatic duct stent to occlude the residual main pancreatic duct.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveThis study aims to evaluate the feasibility and potential advantages of a novel technique for sealing the residual main pancreatic duct by inserting a stent into the distal pancreatic duct during laparoscopic distal pancreatectomy.
methodsA retrospective analysis was performed on patients who underwent laparoscopic distal pancreatectomy at our institution between June 2021 and June 2023. A total of 38 patients were included, with 18 undergoing the novel sealing technique and 20 receiving conventional methods (control group). Postoperative outcomes, including the overall incidence of pancreatic fistula, the incidence of grade B and C fistulas, time to drain removal, length of hospital stay, and other short-term clinical parameters, were statistically compared between the two groups.
resultsThe overall pancreatic fistula incidence was 72.2% in the experimental group and 65.0% in the control group, with no statistically significant difference between the two groups. However, the incidence of grade B and C pancreatic fistulas in the experimental group was 11.1%, which was significantly lower than the 45.0% observed in the control group (P = 0.033). Additionally, the average operative time, postoperative abdominal drain removal time, and hospital stay were all significantly shorter in the experimental group compared to the control group. No significant differences were observed in other perioperative outcome measures between the two groups.
conclusionThe novel technique for sealing the residual pancreatic duct demonstrates safety and feasibility, and contributes to improved patient outcomes.
Indexed as
Identifiers
41714453What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.